1. Home
  2. CRNX vs CIVI Comparison

CRNX vs CIVI Comparison

Compare CRNX & CIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • CIVI
  • Stock Information
  • Founded
  • CRNX 2008
  • CIVI 1999
  • Country
  • CRNX United States
  • CIVI United States
  • Employees
  • CRNX N/A
  • CIVI N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • CIVI Oil & Gas Production
  • Sector
  • CRNX Health Care
  • CIVI Energy
  • Exchange
  • CRNX Nasdaq
  • CIVI Nasdaq
  • Market Cap
  • CRNX 2.8B
  • CIVI 2.6B
  • IPO Year
  • CRNX 2018
  • CIVI 2011
  • Fundamental
  • Price
  • CRNX $39.96
  • CIVI $27.40
  • Analyst Decision
  • CRNX Buy
  • CIVI Hold
  • Analyst Count
  • CRNX 12
  • CIVI 13
  • Target Price
  • CRNX $74.45
  • CIVI $42.40
  • AVG Volume (30 Days)
  • CRNX 1.2M
  • CIVI 2.3M
  • Earning Date
  • CRNX 11-06-2025
  • CIVI 11-06-2025
  • Dividend Yield
  • CRNX N/A
  • CIVI 7.59%
  • EPS Growth
  • CRNX N/A
  • CIVI N/A
  • EPS
  • CRNX N/A
  • CIVI 7.93
  • Revenue
  • CRNX $1,392,000.00
  • CIVI $4,815,808,000.00
  • Revenue This Year
  • CRNX $405.68
  • CIVI N/A
  • Revenue Next Year
  • CRNX $1,034.87
  • CIVI N/A
  • P/E Ratio
  • CRNX N/A
  • CIVI $3.32
  • Revenue Growth
  • CRNX 0.51
  • CIVI 0.23
  • 52 Week Low
  • CRNX $24.10
  • CIVI $22.79
  • 52 Week High
  • CRNX $62.53
  • CIVI $55.35
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 44.22
  • CIVI 44.22
  • Support Level
  • CRNX $41.41
  • CIVI $25.78
  • Resistance Level
  • CRNX $43.89
  • CIVI $27.73
  • Average True Range (ATR)
  • CRNX 1.94
  • CIVI 1.06
  • MACD
  • CRNX -0.41
  • CIVI 0.00
  • Stochastic Oscillator
  • CRNX 17.99
  • CIVI 56.82

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About CIVI Civitas Resources Inc.

Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.

Share on Social Networks: